Decentralized clinical trials - A more patient-centric approach

Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.


Open PDF

Return to Insights Center

Related Insights

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Including patients in DCT design

Sep 13, 2022

Video

The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?

Feb 1, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Podcast

Decentrally Speaking | Episode 3: Integrating the Patient Voice into Decentralized Trials

Jul 28, 2022

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023